BioSpace News Archive

Pixee Medical, a pioneer in augmented surgical guidance technology, has announced that its Knee+ AR computer-assisted orthopedic solution is going to be commercially available in the USA with a perfect fit for Ambulatory Surgical Centers need.

Adhera Therapeutics, Inc. is pleased to announce the appointment of Jean Buteau, PhD., to the Company’s Scientific Advisory Board.

3billion announced that Chief Medical Officer Dr. Go Hun Seo will introduce a research poster at ACMG annual meeting 2022, held in Nashville, TN, from March 22 through 26.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced a new supply agreement with the Swiss Federal Government for seven million doses of Moderna’s COVID-19 booster vaccine for anticipated delivery in 2023 and an additional option of seven million doses for delivery in 2023 and 2024.

Volastra Therapeutics, an oncology company focused on exploiting chromosomal instability as a vulnerability for cancer cells, announced a collaboration with Bristol Myers Squibb to discover, develop and commercialize new medicines.

BioAge Labs, Inc., a biotechnology company developing medications that target the molecular causes of aging to extend healthy human lifespan, announced that its clinical-stage oral drug BGE-175, which targets age-related immune deficiencies, protects aged mice from lethal infection with SARS-CoV-2, the virus that causes COVID-19.

Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that chairperson and chief executive officer, Tony Coles, M.D. will participate in a fireside chat at the Stifel 4th Annual CNS Day on Tuesday, March 29, 2022 at 9:00 a.m. EDT.

Henry Schein’s presentation can be heard via live webcast by visiting www.henryschein.com/IRwebcasts.

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), today announces financial results for the fourth quarter and year ended December 31, 2021 and provides a corporate update.

Athira Pharma, Inc. announced that members of Athira Pharma’s senior management team will participate in the following upcoming investor conferences.